276
Views
0
CrossRef citations to date
0
Altmetric
Original Investigations

Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes

, , , , , , , , , , , , & show all
Pages 208-218 | Received 13 Jan 2021, Accepted 02 Jun 2021, Published online: 02 Aug 2021

References

  • Åberg K, Saetre P, Lindholm E, Ekholm B, Pettersson U, Adolfsson R, Jazin E. 2006. Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B. 141(1):84–90.
  • Agim ZS, Esendal M, Briollais L, Uyan O, Meschian M, Martinez LAM, Ding Y, Basak AN, Ozcelik H. 2013. Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PLOS One. 8(1):e53042.
  • Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, et al. 2012. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 17(9):887–905.
  • Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature. 489:57–74. https://doi.org/10.1038/nature11247.
  • Calle ML, Urrea V, Malats N, van Steen K. 2010. Mbmdr: an R package for exploring gene-gene interactions associated with binary or quantitative traits. Bioinformatics. 26(17):2198–2199.
  • Cao F, Yin A, Wen G, Sheikh AM, Tauqeer Z, Malik M, Nagori A, Schirripa M, Schirripa F, Merz G, et al. 2012. Alteration of astrocytes and Wnt/β-catenin signaling in the frontal cortex of autistic subjects. J Neuroinflammation. 9:223.
  • Catani M, Ffytche DH. 2005. The rises and falls of disconnection syndromes. Brain. 128(Pt 10):2224–2239.
  • Chen S, Velardez MO, Warot X, Yu Z-X, Miller SJ, Cros D, Corfas G. 2006. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J Neurosci. 26(12):3079–3086.
  • Cordell HJ, Barratt BJ, Clayton DG. 2004. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol. 26(3):167–185.
  • Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M, Sparen P. 2008. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics. 121(5):e1357–e1362.
  • Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry. 60(5):443–456.
  • de Lacy N, King BH. 2013. Revisiting the relationship between autism and schizophrenia: to ward an integrated neurobiology. Annu Rev Clin Psychol. 9:555–587.
  • Dennis EL, Thompson PM. 2013. Typical and atypical brain development: a review of neuroimaging studies. Dialog Clin Neurosci. 15(3):359–384.
  • Duncan LE, Holmans PA, Lee PH, O'Dushlaine CT, Kirby AW, Smoller JW, Öngür D, Cohen BM. 2014. Pathway analyses implicate glial cells in schizophrenia. PLOS One. 9(2):e89441.
  • Figlia G, Norrmén C, Pereira JA, Gerber D, Suter U. 2017. Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system. Elife. 6:e29241.
  • Flores AI, Narayanan SP, Morse EN, Shick HE, Yin X, Kidd G, Avila RL, Kirschner DA, Macklin WB. 2008. Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci. 28(28):7174–7183.
  • Ford JM, Mathalon DH, Whitfield S, Faustman WO, Roth WT. 2002. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry. 51(6):485–492.
  • Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. 2013. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41(Database issue):D808–D815.
  • Goudriaan A, de Leeuw C, Ripke S, Hultman CM, Sklar P, Sullivan PF, Smit AB, Posthuma D, Verheijen MHG. 2014. Specific glial functions contribute to schizophrenia susceptibility. Schizophr Bull. 40(4):925–935.
  • Guan J, Cai JJ, Ji G, Sham PC. 2019. Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder. Transl Psychiatry. 9(1):152.
  • Habela CW, Song H, Li MG. 2016. Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons. Mol Cell Neurosci. 73:52–62.
  • Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, et al. 2006. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 12(7):824–828.
  • Hammerschlag AR, de Leeuw CA, Middeldorp CM, Polderman TJC. 2019. Synaptic and brain-expressed gene sets relate to the shared genetic risk across five psychiatric disorders. Psychol Med. 50(10):1695–1705.
  • Harrison PJ, Law AJ. 2006. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry. 60(2):132–140.
  • Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. 2004. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry. 9(3):299–307.
  • Karlsgodt KH. 2020. White matter microstructure across the psychosis spectrum. Trends Neurosci. 43:406–416.
  • Karoutzou G, Emrich HM, Dietrich DE. 2008. The myelin-pathogenesis puzzle in schizophrenia: a literature review. Mol Psychiatry. 13(3):245–260.
  • Katz J, d'Albis MA, Boisgontier J, Poupon C, Mangin JF, Guevara P, Duclap D, Hamdani N, Petit J, Monnet D, et al. 2016. Similar white matter but opposite grey matter changes in schizophrenia and high-functioning autism. Acta Psychiatr Scand. 134(1):31–39.
  • Kerns JG, Nuechterlein KH, Braver TS, Barch DM. 2008. Executive functioning component mechanisms and schizophrenia. Biol Psychiatry. 64(1):26–33.
  • Konrad A, Winterer G. 2008. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull. 34(1):72–92.
  • Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR. 2006. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci USA. 103(17):6747–6752.
  • Lee PR. 2009. Regulation of myelin genes implicated in psychiatric disorders by functional activity in axons. Front Neuroanat. 3:4.
  • Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, et al. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 45(9):984–994. https://doi.org/10.1038/ng.2711.
  • Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 15(12):1995–2002.
  • Li J, Shi M, Ma Z, Zhao S, Euskirchen G, Ziskin J, Urban A, Hallmayer J, Snyder M. 2014. Integrated systems analysis reveals a molecular network underlying autism spectrum disorders. Mol Syst Biol. 10:774.
  • Markham JA, Greenough WT. 2004. Experience-driven brain plasticity: beyond the synapse. Neuron Glia Biol. 1(4):351–363.
  • Martinez G, Mosconi E, Daban-Huard C, Parellada M, Fananas L, Gaillard R, Fatjo-Vilas M, Krebs MO, Amado I. 2019. “A circle and a triangle dancing together”: alteration of social cognition in schizophrenia compared to autism spectrum disorders. Schizophr Res. 210:94–100.
  • Mei L, Nave KA. 2014. Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron. 83(1):27–49.
  • Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, Everall IP. 2010. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry. 68(4):368–376.
  • Mostaid MS, Mancuso SG, Liu C, Sundram S, Pantelis C, Everall IP, Bousman CA. 2017. Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia. Transl Psychiatry. 7(1):e1004.
  • Mueller S, Keeser D, Reiser MF, Teipel S, Meindl T. 2012. Functional and structural MR imaging in neuropsychiatric disorders, part 2: application in schizophrenia and autism. AJNR Am J Neuroradiol. 33:2033–2037.
  • Nicodemus KK, Luna A, Vakkalanka R, Goldberg T, Egan M, Straub RE, Weinberger DR. 2006. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry. 11(12):1062–1065.
  • Norrmén C, Suter U. 2013. Akt/mTOR signalling in myelination. Biochem Soc Trans. 41(4):944–950.
  • Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM, Williams HJ, Preece AC, Dwyer S, Wilkinson JC, et al. 2006. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet B. 141(1):96–101.
  • O’dushlaine C, Rossin L, Lee PH, Duncan L, Parikshak NN, Newhouse S, Ripke S, Neale BM, Purcell SM, Posthuma D, et al. 2015. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 18(12):199–209.
  • Papiol S, Mitjans M, Assogna F, Piras F, Hammer C, Caltagirone C, Arias B, Ehrenreich H, Spalletta G. 2014. Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample. Transl Psychiatry. 4:e362.
  • Park J, Sarode VR, Euhus D, Kittler R, Scherer PE. 2012. Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer. Proc Natl Acad Sci USA. 109(51):21058–21063.
  • Paus T, Keshavan M, Giedd JN. 2008. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 9(12):947–957.
  • Pernet V, Joly S, Christ F, Dimou L, Schwab ME. 2008. Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci. 28(29):7435–7444.
  • Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, Lee P, Bulik-Sullivan B, Collier DA, Huang H, et al. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 511:421–427.
  • Roussos P, Haroutunian V. 2014. Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. Front Cell Neurosci. 8:5.
  • Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, Chen C, Moore H, O'Donnell P, et al. 2007. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci USA. 104(19):8131–8136.
  • Sasson NJ, Pinkham AE, Carpenter KLH, Belger A. 2011. The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment. J Neurodev Disord. 3(2):87–100.
  • Segal D, Koschnick JR, Slegers LHA, Hof PR. 2007. Oligodendrocyte pathophysiology: a new view of schizophrenia. Int J Neuropsychopharmacol. 10(4):503–511.
  • Stahlberg O, Soderstrom H, Rastam M, Gillberg C. 2004. Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm. 111(7):891–902.
  • Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71(4):877–892.
  • Sullivan S, Rai D, Golding J, Zammit S, Steer C. 2013. The association between autism spectrum disorder and psychotic experiences in the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort. J Am Acad Child Adolesc Psychiatry. 52(8):806–814.e2.
  • Sullivan PF, Magnusson C, Reichenberg A, Boman M, Dalman C, Davidson M, Fruchter E, Hultman CM, Lundberg M, Långström N, et al. 2012. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 69(11):1099–1103.
  • Tau GZ, Peterson BS. 2010. Normal development of brain circuits. Neuropsychopharmacology. 35(1):147–168.
  • Terwisscha van Scheltinga AF, Bakker SC, van Haren NEM, Derks EM, Buizer-Voskamp JE, Boos HBM, Cahn W, Hulshoff Pol HE, Ripke S, Ophoff RA, et al. 2013. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry. 73(6):525–531.
  • Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 55(5):597–610.
  • Ward LD, Kellis M. 2012. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 40:D930-4.
  • Wehr MC, Hinrichs W, Brzózka MM, Unterbarnscheidt T, Herholt A, Wintgens JP, Papiol S, Soto‐Bernardini MC, Kravchenko M, Zhang M, et al. 2017. Spironolactone is an antagonist of NRG 1‐ERBB 4 signaling and schizophrenia‐relevant endophenotypes in mice. EMBO Mol Med. 9(10):1448–1462.
  • Weickert CS, Tiwari Y, Schofield PR, Mowry BJ, Fullerton JM. 2012. Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Transl Psychiatry. 2(4):e104.
  • Wheeler AL, Voineskos AN. 2014. A review of structural neuroimaging in schizophrenia: from connectivity to connectomics. Front Hum Neurosci. 8:653.
  • Wolff JJ, Gerig G, Lewis JD, Soda T, Styner MA, Vachet C, Botteron KN, Elison JT, Dager SR, Estes AM, et al. IBIS Network. 2015. Altered corpus callosum morphology associated with autism over the first 2 years of life. Brain. 138(Pt 7):2046–2058.
  • Yin L, Cheung EFC, Chen RYL, Wong EHM, Sham PC, So HC. 2018. Leveraging genome-wide association and clinical data in revealing schizophrenia subgroups. J Psychiatr Res. 106:106–117.
  • Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN. 2006. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34(Suppl 2):W635–W641.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.